Many doctors, researchers and patients are eager to take advantage of the promise of stem cell therapies to heal damaged tissues and replace dysfunctional cells. Hundreds of ongoing clinical trials are currently delivering these therapies to patients worldwide.
You are here
Coverage of the latest news and updates from the field of stem cells.
New research from the University of California Los Angeles (UCLA) could help explain the link between a high-cholesterol diet and an elevated risk for colon cancer.
In a scientific first, researchers at the Gladstone Institutes turned skin cells from mice into stem cells by activating a specific gene in the cells using CRISPR technology.
Can tumors teach us about animal evolution on Earth? Researchers believe so and now present a novel hypothesis of why animal diversity increased dramatically on Earth about half a billion years ago.
A biological innovation may have been key.
Colon cancer is the third most common cancer and fourth most common cause of death worldwide. Colon tumors consist of different types of cells, which play different roles in the growth of the tumor.
In cooperation with colleagues from the Wyss Institute at Harvard, researchers from the Julius Wolff Institute of the Charité – Universitätsmedizin Berlin, the Berlin-Brandenburg Center for Regenerative Therapies (BCRT) and Charité’s Center for Musculoskeletal Surgery have shown ho
Although cardiac stem cell therapy is a promising treatment for heart attack patients, directing the cells to the site of an injury – and getting them to stay there – remains challenging.
Scientists at the National Eye Institute (NEI), part of the National Institutes of Health, report that tiny tube-like protrusions called primary cilia on cells of the retinal pigment epithelium (RPE) — a layer of cells in the back of the eye — are essential for the survival of the retina’s light-
Researchers at Osaka University have developed a synthetic tissue for treating damaged cartilage, which had previously been incurable and had no effective therapies. Their method uses synovium-derived mesenchymal stem cells (MSCs) as the starting material.
Scleroderma with internal organ involvement is a debilitating and lethal autoimmune disorder with few effective treatments. But a study led by Duke Health researchers has found new cause for optimism using an aggressive stem cell transplant regimen.